|
Volumn 37, Issue 1, 2001, Pages 47-51
|
The treatment of undifferentiated neuroendocrine tumors
|
Author keywords
Cisplatin; Drug therapy; Etoposide; Neuroendocrine tumors; Pathology; Survival analysis
|
Indexed keywords
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
ETOPOSIDE;
FLUOROURACIL;
LOMUSTINE;
PACLITAXEL;
ARTICLE;
BONE MARROW SUPPRESSION;
CANCER REGRESSION;
CANCER SURVIVAL;
HUMAN;
NEPHROTOXICITY;
NEUROENDOCRINE TUMOR;
PROGNOSIS;
SIDE EFFECT;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NEUROENDOCRINE;
CELL DIFFERENTIATION;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
NEUROENDOCRINE TUMORS;
PROGNOSIS;
|
EID: 0035152480
PISSN: 10408428
EISSN: None
Source Type: Journal
DOI: 10.1016/S1040-8428(00)00073-1 Document Type: Article |
Times cited : (22)
|
References (28)
|